- Home
- XAIR vs PRTG Comparison
XAIR vs PRTG Comparison
Compare XAIR & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- PRTG
- Stock Information
- Founded
- XAIR 2011
- PRTG 1973
- Country
- XAIR United States
- PRTG British Virgin Islands
- Employees
- XAIR N/A
- PRTG N/A
- Industry
- XAIR Medical/Dental Instruments
- PRTG Oil & Gas Production
- Sector
- XAIR Health Care
- PRTG Energy
- Exchange
- XAIR Nasdaq
- PRTG Nasdaq
- Market Cap
- XAIR 17.0M
- PRTG 17.7M
- IPO Year
- XAIR N/A
- PRTG N/A
- Fundamental
- Price
- XAIR $2.25
- PRTG $9.11
- Analyst Decision
- XAIR Strong Buy
- PRTG
- Analyst Count
- XAIR 1
- PRTG 0
- Target Price
- XAIR $11.00
- PRTG N/A
- AVG Volume (30 Days)
- XAIR 190.1K
- PRTG 50.2K
- Earning Date
- XAIR 08-12-2025
- PRTG 09-02-2025
- Dividend Yield
- XAIR N/A
- PRTG N/A
- EPS Growth
- XAIR N/A
- PRTG N/A
- EPS
- XAIR N/A
- PRTG N/A
- Revenue
- XAIR $4,782,000.00
- PRTG N/A
- Revenue This Year
- XAIR $266.61
- PRTG N/A
- Revenue Next Year
- XAIR $140.76
- PRTG N/A
- P/E Ratio
- XAIR N/A
- PRTG N/A
- Revenue Growth
- XAIR 168.20
- PRTG N/A
- 52 Week Low
- XAIR $2.02
- PRTG $2.42
- 52 Week High
- XAIR $13.52
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- XAIR 35.48
- PRTG 63.55
- Support Level
- XAIR $2.02
- PRTG $7.58
- Resistance Level
- XAIR $2.42
- PRTG $9.30
- Average True Range (ATR)
- XAIR 0.20
- PRTG 1.03
- MACD
- XAIR -0.04
- PRTG 0.03
- Stochastic Oscillator
- XAIR 17.97
- PRTG 73.85
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.